Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of [18F]-Florbetapir in Parkinson's disease Dementia (PDD) patients

Trial Profile

Study of [18F]-Florbetapir in Parkinson's disease Dementia (PDD) patients

Phase of Trial: Phase II

Latest Information Update: 27 Nov 2018

At a glance

  • Drugs Florbetapir F 18 (Primary)
  • Indications Dementia; Parkinson's disease
  • Focus Diagnostic use
  • Most Recent Events

    • 27 Nov 2018 New trial record
    • 09 Oct 2018 Results presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top